|
Statement
| 1.Date of occurrence of the change:2022/05/20
2.Name of legal person:
(1)Lejean Biotech Co., Ltd.
(2)Wechen Co. Ltd.
(3)Po Chang Investment Co., Ltd.
3.Name of the previous position holder:
(1)LeJean Biotech Co., Ltd. appointed Lin, Chia-Ling to present .
(2)Wechen Co. Ltd. appointed Tsai, Pei-Chen to present.
(3)Po Chang Investment Co., Ltd. appointed Chen, Chun-Hong to present.
4.Resume of the previous position holder:
(1)Lin, Chia-Ling:Director of Mycenax Biotech Inc.
(2)Tsai, Pei-Chen:Director of Center Laboratories, Inc.
(3)Chen, Chun-Hong:Chairman of MasterLink Securities Corporation.
5.Name of the new position holder:
(1)LeJean Biotech Co., Ltd. appointed Lin, Chia-Ling to present.
(2)Wechen Co. Ltd. appointed Tsai, Pei-Chen to present.
(3)Po Chang Investment Co., Ltd. appointed Chen, Chun-Hong to present.
6.Resume of the new position holder:
(1)Lin, Chia-Ling:Director of Mycenax Biotech Inc.
(2)Tsai, Pei-Chen:Director of Center Laboratories, Inc.
(3)Chen, Chun-Hong:Chairman of MasterLink Securities Corporation.
7.Reason for the change:
Re-election of Board of Directors, the newly elected institutional
director appointed representative.
8.Original term (from __________ to __________):
2019/06/24~2022/06/23
9.Effective date of the new appointment:2022/05/20
10.Any other matters that need to be specified:None.
|